da Silva A, Praca M, Lamaita R, Batista Candido E, Paiva L, Soares J
Rev Bras Ginecol Obstet. 2025; 47.
PMID: 39926120
PMC: 11805534.
DOI: 10.61622/rbgo/2025FPS1.
Dellino M, Damato A, Battista G, Cormio G, Vimercati A, Loizzi V
Open Med (Wars). 2024; 19(1):20249999.
PMID: 39176249
PMC: 11340857.
DOI: 10.1515/med-2024-9999.
Magaton I, Arecco L, Mariamidze E, Jankovic K, Stana M, Buzzatti G
Breast Cancer (Auckl). 2024; 18:11782234241261429.
PMID: 38882447
PMC: 11179469.
DOI: 10.1177/11782234241261429.
Silvestris E, Cormio G, Loizzi V, Corrado G, Arezzo F, Petracca E
Life (Basel). 2024; 14(5).
PMID: 38792636
PMC: 11122448.
DOI: 10.3390/life14050615.
Weizel I, Shavit T, Shuli Y, Adler Lazarovich C, Halevi R, Ben Ari T
Reprod Biol Endocrinol. 2024; 22(1):8.
PMID: 38172815
PMC: 10762833.
DOI: 10.1186/s12958-023-01180-9.
Preimplantation genetic testing for monogenic disorders: clinical experience with BRCA1 and BRCA2 from 2010-2021.
Barrett F, Shaw J, Besser A, Grifo J, Blakemore J
J Assist Reprod Genet. 2023; 40(11):2705-2713.
PMID: 37691027
PMC: 10643755.
DOI: 10.1007/s10815-023-02925-6.
Fertility restoration in mice with chemotherapy induced ovarian failure using differentiated iPSCs.
Elias K, Ng N, Dam K, Milne A, Disler E, Gockley A
EBioMedicine. 2023; 94:104715.
PMID: 37482511
PMC: 10435842.
DOI: 10.1016/j.ebiom.2023.104715.
Ovarian reserve in reproductive-aged patients with cancer before gonadotoxic treatment: a systematic review and meta-analysis.
Wu M, Zhu Q, Huang Y, Tang W, Dai J, Guo Y
Hum Reprod Open. 2023; 2023(3):hoad024.
PMID: 37325546
PMC: 10266964.
DOI: 10.1093/hropen/hoad024.
BRCA, infertility, and fertility preservation: a review for counseling.
Baltaci E, Kazanci F, Sahin F
J Assist Reprod Genet. 2023; 40(3):465-472.
PMID: 36695945
PMC: 10033813.
DOI: 10.1007/s10815-023-02725-y.
Providers' perspectives on the reproductive decision-making of BRCA-positive women.
Dason E, Drost L, Greenblatt E, Scheer A, Han J, Sobel M
BMC Womens Health. 2022; 22(1):506.
PMID: 36482357
PMC: 9730610.
DOI: 10.1186/s12905-022-02093-2.
Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis.
Liu X, Yue J, Pervaiz R, Zhang H, Wang L
Front Endocrinol (Lausanne). 2022; 13:986477.
PMID: 36176466
PMC: 9513064.
DOI: 10.3389/fendo.2022.986477.
BRCA1/2 pathogenetic variant carriers and reproductive decisions: Gender differences and factors associated with the choice of preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND).
Lombardi L, Trumello C, Stuppia L, Antonucci I, Brandao T, Babore A
J Assist Reprod Genet. 2022; 39(7):1433-1443.
PMID: 35661074
PMC: 9365893.
DOI: 10.1007/s10815-022-02523-y.
BRCA1: An Endocrine and Metabolic Regulator.
Werner H
Front Endocrinol (Lausanne). 2022; 13:844575.
PMID: 35432218
PMC: 9009035.
DOI: 10.3389/fendo.2022.844575.
Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
Michaan N, Leshno M, Cohen Y, Safra T, Peleg-Hasson S, Laskov I
Reprod Biol Endocrinol. 2021; 19(1):153.
PMID: 34620184
PMC: 8499576.
DOI: 10.1186/s12958-021-00827-9.
Reproductive issues in carriers of germline pathogenic variants in the BRCA1/2 genes: an expert meeting.
Buonomo B, Massarotti C, Dellino M, Anserini P, Ferrari A, Campanella M
BMC Med. 2021; 19(1):205.
PMID: 34503502
PMC: 8431919.
DOI: 10.1186/s12916-021-02081-7.
Meiotic Recombination Defects and Premature Ovarian Insufficiency.
Huang C, Guo T, Qin Y
Front Cell Dev Biol. 2021; 9:652407.
PMID: 33763429
PMC: 7982532.
DOI: 10.3389/fcell.2021.652407.
Long-term Health Consequences of Endometriosis - Pathways and Mediation by Treatment.
Farland L, Harris H
Curr Obstet Gynecol Rep. 2021; 9(3):79-88.
PMID: 33552675
PMC: 7864355.
DOI: 10.1007/s13669-020-00287-9.
Reduced translation efficiency due to novel splicing variants in 5' untranslated region and identification of novel cis-regulatory elements in canine and human BRCA2.
Yoshikawa Y, Kozuma H, Morimatsu M, Sugawara K, Orino K
BMC Mol Cell Biol. 2021; 22(1):2.
PMID: 33407082
PMC: 7788759.
DOI: 10.1186/s12860-020-00336-4.
Concerns regarding the potentially causal role of FANCA heterozygous variants in human primary ovarian insufficiency.
Heddar A, Misrahi M
Hum Genet. 2020; 140(4):691-694.
PMID: 33151384
DOI: 10.1007/s00439-020-02232-5.
Genetics of Primary Ovarian Insufficiency in the Next-Generation Sequencing Era.
Franca M, Mendonca B
J Endocr Soc. 2020; 4(2):bvz037.
PMID: 32099950
PMC: 7033037.
DOI: 10.1210/jendso/bvz037.